Cargando…
Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?
BACKGROUND: We aimed to investigate whether visceral adiposity could modify the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes. METHODS: This cross-sectional study examines the interaction of visceral adiposity with increased blood pressure on arteria...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721003/ https://www.ncbi.nlm.nih.gov/pubmed/26790628 http://dx.doi.org/10.1186/s12933-016-0335-3 |
_version_ | 1782411158163030016 |
---|---|
author | Bouchi, Ryotaro Ohara, Norihiko Asakawa, Masahiro Nakano, Yujiro Takeuchi, Takato Murakami, Masanori Sasahara, Yuriko Numasawa, Mitsuyuki Minami, Isao Izumiyama, Hajime Hashimoto, Koshi Yoshimoto, Takanobu Ogawa, Yoshihiro |
author_facet | Bouchi, Ryotaro Ohara, Norihiko Asakawa, Masahiro Nakano, Yujiro Takeuchi, Takato Murakami, Masanori Sasahara, Yuriko Numasawa, Mitsuyuki Minami, Isao Izumiyama, Hajime Hashimoto, Koshi Yoshimoto, Takanobu Ogawa, Yoshihiro |
author_sort | Bouchi, Ryotaro |
collection | PubMed |
description | BACKGROUND: We aimed to investigate whether visceral adiposity could modify the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes. METHODS: This cross-sectional study examines the interaction of visceral adiposity with increased blood pressure on arterial stiffness and albuminuria. 638 patients with type 2 diabetes (mean age 64 ± 12 years; 40 % female) were enrolled. Visceral fat area (VFA, cm(2)) was assessed by a dual-impedance analyzer, whereby patients were divided into those with VFA < 100 (N = 341) and those with VFA ≥ 100 (N = 297). Albuminuria was measured in a single 24-h urine collection (UAE, mg/day) and brachial-ankle pulse wave velocity (ba-PWV, cm/s) was used for the assessment of arterial stiffening. Linear regression analyses were used to investigate the association of systolic blood pressure (SBP) and VFA with UAE and baPWV. RESULTS: Patients with VFA ≥ 100 were significantly younger, had higher SBP, HbA1c, triglycerides, UAE, alanine aminotransferase, C-reactive protein and lower high-density lipoprotein and shorter duration of diabetes than those with VFA < 100. SBP was significantly and almost equivalently associated with ba-PWV both in VFA < 100 (standardized β 0.224, p = 0.001) and VFA ≥ 100 (standardized β 0.196, p = 0.004) patients in the multivariate regression analysis adjusting for covariates including age, gender, HbA1c, diabetic complications and the use of insulin and anti-hypertensive agents. By contrast, the association of SBP with UAE was stronger in patients with VFA ≥ 100 (standardized β 0.263, p = 0.001) than that in patients with VFA < 100 (standardized β 0.140, p = 0.080) in the multivariate regression model. In the whole cohort, the significant interaction between SBP and VFA on UAE (standardized β 0.172, p = 0.040) but not on ba-PWV (standardized β −0.008, p = 0.916) was observed. CONCLUSIONS: The effect of increased blood pressure on arterial stiffness is almost similar in type 2 diabetic patients with both low and high visceral adiposity, while its association with albuminuria is stronger in the latter. |
format | Online Article Text |
id | pubmed-4721003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47210032016-01-22 Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? Bouchi, Ryotaro Ohara, Norihiko Asakawa, Masahiro Nakano, Yujiro Takeuchi, Takato Murakami, Masanori Sasahara, Yuriko Numasawa, Mitsuyuki Minami, Isao Izumiyama, Hajime Hashimoto, Koshi Yoshimoto, Takanobu Ogawa, Yoshihiro Cardiovasc Diabetol Original Investigation BACKGROUND: We aimed to investigate whether visceral adiposity could modify the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes. METHODS: This cross-sectional study examines the interaction of visceral adiposity with increased blood pressure on arterial stiffness and albuminuria. 638 patients with type 2 diabetes (mean age 64 ± 12 years; 40 % female) were enrolled. Visceral fat area (VFA, cm(2)) was assessed by a dual-impedance analyzer, whereby patients were divided into those with VFA < 100 (N = 341) and those with VFA ≥ 100 (N = 297). Albuminuria was measured in a single 24-h urine collection (UAE, mg/day) and brachial-ankle pulse wave velocity (ba-PWV, cm/s) was used for the assessment of arterial stiffening. Linear regression analyses were used to investigate the association of systolic blood pressure (SBP) and VFA with UAE and baPWV. RESULTS: Patients with VFA ≥ 100 were significantly younger, had higher SBP, HbA1c, triglycerides, UAE, alanine aminotransferase, C-reactive protein and lower high-density lipoprotein and shorter duration of diabetes than those with VFA < 100. SBP was significantly and almost equivalently associated with ba-PWV both in VFA < 100 (standardized β 0.224, p = 0.001) and VFA ≥ 100 (standardized β 0.196, p = 0.004) patients in the multivariate regression analysis adjusting for covariates including age, gender, HbA1c, diabetic complications and the use of insulin and anti-hypertensive agents. By contrast, the association of SBP with UAE was stronger in patients with VFA ≥ 100 (standardized β 0.263, p = 0.001) than that in patients with VFA < 100 (standardized β 0.140, p = 0.080) in the multivariate regression model. In the whole cohort, the significant interaction between SBP and VFA on UAE (standardized β 0.172, p = 0.040) but not on ba-PWV (standardized β −0.008, p = 0.916) was observed. CONCLUSIONS: The effect of increased blood pressure on arterial stiffness is almost similar in type 2 diabetic patients with both low and high visceral adiposity, while its association with albuminuria is stronger in the latter. BioMed Central 2016-01-21 /pmc/articles/PMC4721003/ /pubmed/26790628 http://dx.doi.org/10.1186/s12933-016-0335-3 Text en © Bouchi et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Bouchi, Ryotaro Ohara, Norihiko Asakawa, Masahiro Nakano, Yujiro Takeuchi, Takato Murakami, Masanori Sasahara, Yuriko Numasawa, Mitsuyuki Minami, Isao Izumiyama, Hajime Hashimoto, Koshi Yoshimoto, Takanobu Ogawa, Yoshihiro Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? |
title | Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? |
title_full | Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? |
title_fullStr | Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? |
title_full_unstemmed | Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? |
title_short | Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? |
title_sort | is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes? |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721003/ https://www.ncbi.nlm.nih.gov/pubmed/26790628 http://dx.doi.org/10.1186/s12933-016-0335-3 |
work_keys_str_mv | AT bouchiryotaro isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT oharanorihiko isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT asakawamasahiro isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT nakanoyujiro isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT takeuchitakato isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT murakamimasanori isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT sasaharayuriko isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT numasawamitsuyuki isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT minamiisao isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT izumiyamahajime isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT hashimotokoshi isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT yoshimototakanobu isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes AT ogawayoshihiro isvisceraladiposityamodifierfortheimpactofbloodpressureonarterialstiffnessandalbuminuriainpatientswithtype2diabetes |